Iovance Biotherapeutics (NASDAQ:IOVA) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Iovance Biotherapeutics (IOVA) operate in?

Iovance Biotherapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Iovance Biotherapeutics Stock (NASDAQ: IOVA) stock price, news, charts, stock research, profile.

Open	$8.15
Close	$8.24
Volume / Avg.	4.42M / 6.26M
Day Range	$7.98 - $8.38
52 Wk Range	5.14 - 18.33
Market Cap	$2.50B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	34
Short Interest	21.66%
Days to Cover	11.53

Recent News

AST SpaceMobile And Polestar Automotive Are Among Top 10 Best Performing Mid-Cap Stocks in August: Are The Others In Your Portfolio?

The top 10 mid-cap stocks in August: Polestar Automotive, Upstart, Lumen Technologies, GDS Holdings, Tempus AI, Clear Secure, Iovance Biotherapeutics, Evolent Health, Semtech Corp, AST SpaceMobile.

Lekha Gupta

Expedia Posts Upbeat Earnings, Joins Akamai Technologies, Trade Desk, DXC Technology And Other Big Stocks Moving Higher On Friday

Avi Kapoor

Skin Cancer-Focused Iovance Biotherapeutics Reports Better-Than-Expected 2024, 2025 Outlook, Stock Surges

Iovance Biotherapeutics stock up 23.2% after issuing upbeat guidance for 2024 and 2025, beating Q2 earnings expectations.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Jul

Aug

Oct

Nov

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.8

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$8.15
Close	$8.24
Volume / Avg.	4.42M / 6.26M
Day Range	$7.98 - $8.38
52 Wk Range	5.14 - 18.33
Market Cap	$2.50B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	34
Short Interest	21.66%
Days to Cover	11.53

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Iovance Biotherapeutics (IOVA) stock?

You can purchase shares of Iovance Biotherapeutics (NASDAQ:IOVA) through any online brokerage.

View our list of the best stock brokerages

Who are Iovance Biotherapeutics (IOVA) competitors?

Other companies in Iovance Biotherapeutics’s space includes: IDEAYA Biosciences (NASDAQ:IDYA), Twist Bioscience (NASDAQ:TWST), Centessa Pharmaceuticals (NASDAQ:CNTA), SpringWorks Therapeutics (NASDAQ:SWTX) and Protagonist Therapeutics (NASDAQ:PTGX).

What is the forecast, or price target, for Iovance Biotherapeutics (IOVA) stock?

Iovance Biotherapeutics has a consensus price target of $21.18.

What is the current price for Iovance Biotherapeutics (IOVA)?

The stock price for Iovance Biotherapeutics (NASDAQ: IOVA) is $8.19 last updated November 21, 2024 at 6:45 PM EST.

Does Iovance Biotherapeutics (IOVA) pay a dividend?

There are no upcoming dividends for Iovance Biotherapeutics.

When is Iovance Biotherapeutics (NASDAQ:IOVA) reporting earnings?

Iovance Biotherapeutics’s Q3 earnings are confirmed for Thursday, November 7, 2024.

Is Iovance Biotherapeutics (IOVA) going to split?

There is no upcoming split for Iovance Biotherapeutics.

What sector and industry does Iovance Biotherapeutics (IOVA) operate in?

Iovance Biotherapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

Iovance Biotherapeutics

Iovance Biotherapeutics (IOVA) Forecast